WithdrawnPhase 1NCT01825369
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
Studying Atrioventricular septal defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Jeffrey Fineman, MDUniversity of California, San Francisco
- Intervention
- IV L-carnitine(drug)
- Eligibility
- All sexes
- Timeline
- 2014 – 2020
Study locations (1)
- University of California San Francisco, San Francisco, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01825369 on ClinicalTrials.govOther trials for Atrioventricular septal defect
Additional recruiting or active studies for the same condition.